Posted by Jonathan D. Rockoff in the Wall Street Journal Health Blog
The federal appeals court in Boston upheld New Hampshire’s law barring the sale of doctor prescribing data, rebuffing the drug industry’s argument that the law infringes free speech.
Drug companies buy the detailed information on prescribing histories from companies like IMS Health and Verispan and use it for everything from tailoring doctor-specific sales pitches to calculating compensation for sales reps. The data houses are the ones challenging New Hampshire’s 2006 Prescription Information Law.
No comments:
Post a Comment